166 related articles for article (PubMed ID: 8443387)
1. Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants.
Shi W; Chong BH; Chesterman CN
Blood; 1993 Mar; 81(5):1255-62. PubMed ID: 8443387
[TBL] [Abstract][Full Text] [Related]
2. Anticardiolipin antibodies block the inhibition by beta 2-glycoprotein I of the factor Xa generating activity of platelets.
Shi W; Chong BH; Hogg PJ; Chesterman CN
Thromb Haemost; 1993 Aug; 70(2):342-5. PubMed ID: 8236146
[TBL] [Abstract][Full Text] [Related]
3. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles.
Galli M; Bevers EM; Comfurius P; Barbui T; Zwaal RF
Br J Haematol; 1993 Mar; 83(3):466-72. PubMed ID: 8485053
[TBL] [Abstract][Full Text] [Related]
4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
5. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
Galli M; Finazzi G; Bevers EM; Barbui T
Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
[TBL] [Abstract][Full Text] [Related]
6. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
7. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects.
Vázquez-Mellado J; Llorente L; Richaud-Patin Y; Alarcón-Segovia D
J Autoimmun; 1994 Jun; 7(3):335-48. PubMed ID: 7916907
[TBL] [Abstract][Full Text] [Related]
8. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
[TBL] [Abstract][Full Text] [Related]
9. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.
McNeil HP; Chesterman CN; Krilis SA
Br J Haematol; 1989 Dec; 73(4):506-13. PubMed ID: 2514785
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
11. Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes.
Willems GM; Janssen MP; Comfurius P; Galli M; Zwaal RF; Bevers EM
Biochemistry; 2000 Feb; 39(8):1982-9. PubMed ID: 10684648
[TBL] [Abstract][Full Text] [Related]
12. Binding specificity of lupus anticoagulants and anticardiolipin antibodies.
McNeil HP; Chesterman CN; Krilis SA
Thromb Res; 1988 Dec; 52(6):609-19. PubMed ID: 3148207
[TBL] [Abstract][Full Text] [Related]
13. Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein.
Arvieux J; Pernod G; Regnault V; Darnige L; Garin J
Blood; 1999 Jun; 93(12):4248-55. PubMed ID: 10361122
[TBL] [Abstract][Full Text] [Related]
14. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
Alving BM; Barr CF; Tang DB
Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
[TBL] [Abstract][Full Text] [Related]
15. Effect of anticardiolipin/beta2-glycoprotein I complexes on production of thromboxane A2 by platelets from patients with the antiphospholipid syndrome.
Robbins DL; Leung S; Miller-Blair DJ; Ziboh V
J Rheumatol; 1998 Jan; 25(1):51-6. PubMed ID: 9458202
[TBL] [Abstract][Full Text] [Related]
16. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
Ordi-Ros J; Pérez-Pemán P; Monasterio J
Haemostasis; 1994; 24(3):165-74. PubMed ID: 7988946
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of the occurrence of beta-2-glycoprotein I antibodies (anti-beta-2-GPI) and anticardiolipin antibodies (ACA) in the blood of pregnant women].
Fialová L; Mikulíková L; Malbohan I; Benesová O; Zwinger A
Ceska Gynekol; 1999 Jul; 64(4):255-61. PubMed ID: 10568065
[TBL] [Abstract][Full Text] [Related]
18. Isolation and purification of anticardiolipin antibody from plasma of a patient with antiphospholipid syndrome: induced generation of platelet thromboxane A2 synthesis.
Leung S; Ziboh VA; Miller-Blair DJ; Robbins DL
Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):385-93. PubMed ID: 9014216
[TBL] [Abstract][Full Text] [Related]
19. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
20. Binding properties of antibodies to prothrombin and beta2-glycoprotein I (beta2-GPI) assayed by ELISA and dot blot.
Forastiero RR; Martinuzzo ME; Carreras LO
Clin Exp Immunol; 1999 Dec; 118(3):480-6. PubMed ID: 10594571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
